Purpose

This study will determine the effectiveness of the antibiotic erythromycin in enhancing gastrointestinal function and decreasing the frequency of binge eating in people with bulimia nervosa.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: NCT00304187
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Blood Samples

Eligibility

Ages Eligible for Study: 18 Years - 55 Years
Genders Eligible for Study: Female
This study is recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
Meets DSM-IV criteria for bulimia nervosa
Duration of illness is greater than 1 year
Self-induces vomiting
Weighs 80%-120 % of ideal weight

Location: 
Clinic: Eating Disorders Clinic
Division: Clinical Psychopharmacology

Study chairs or principal investigators:
B. Timothy Walsh MD, Principal Investigator

Co-investigators:
Michael Devlin,